| Financial Year |
March 31 2023 |
| Monetary Funds |
554,212,530.68 |
| Held-for-trading Financial Assets |
56,427,600.00 |
| Notes Receivable |
94,064,132.95 |
| Accounts Receivable |
1,339,342,008.52 |
| Advances to Suppliers |
132,569,510.18 |
| Other Receivables |
994,739,635.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
771,728,747.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
85,810,782.90 |
| Total Current Assets |
4,077,286,600.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,059,285.54 |
| Investment Properties |
-- |
| Fixed Assetes |
3,098,452,875.08 |
| Under-construction Projects |
655,141,049.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
257,010,280.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,217,000.49 |
| Deferred Income Tax Assets |
21,069,109.01 |
| Other Non-Current Assets |
35,839,761.83 |
| Sub-Total of Non-Current Assets |
4,782,084,118.04 |
| Total Assets |
8,859,370,718.55 |
| Short-Term Loans |
3,098,607,147.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
51,629,695.97 |
| Accounts Payable |
1,807,272,603.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,011,782.08 |
| Taxes Payable |
32,347,969.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
345,326,490.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
364,893,679.33 |
| Other Current Liabilities |
104,773,355.81 |
| Sub-Total of Current Liabilities |
6,172,968,240.48 |
| Long-term Loans |
573,360,454.06 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
77,996,612.13 |
| Special Payable |
-- |
| Estimatied Liabilities |
983,038,221.25 |
| Deferred Income Tax Liabilities |
5,133,065.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,823,502,228.36 |
| Total Liabilities |
7,996,470,468.84 |
| Paid-In Capital(Or Share Stock) |
871,787,068.00 |
| Capital Surplus |
6,134,386,926.04 |
| Surplus Reserve |
216,351,763.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,056,133,178.89 |
| Minority Stockholder's Interest |
-8,265,921.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
871,166,170.74 |
| Owner's Equity（Stockholder's Equity） |
862,900,249.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,859,370,718.55 |
